Skip to main content
. 2021 Feb 17;11:3990. doi: 10.1038/s41598-021-83149-5

Table 1.

The characteristics of the included intrahepatic cholangiocarcinoma patients.

Variables N (%)
Age
< 65 2219 (48.3%)
≥ 65 2376 (51.7%)
Sex
Female 2261 (49.2%)
Male 2334 (50.8%)
Race
Black 391 (8.5%)
White 3555 (77.4%)
API/AI 649 (14.1%)
Marital status
Unmarried 1805 (39.3%)
Married 2790 (60.7%)
Insured status
Uninsured/unknown 793 (17.3%)
Any medicaid/insured 3802 (82.7%)
Year at diagnosis
2004–2007 918 (20.0%)
2008–2011 1419 (30.9%)
2012–2015 2258 (49.1%)
Grade
Grade I/II 1131 (24.6%)
Grade III/IV 918 (20.0%)
Unknown 2546 (55.4%)
Tumor size
< 5 cm 1035 (22.5%)
≥ 5 cm 1993 (43.4%)
Unknown 1567 (34.1%)
AJCC stage
I 821 (17.9%)
II 307 (6.7%)
III 1239 (27.0%)
IV 2228 (48.5%)
Surgery
No surgery 3637 (79.2%)
Local tumor excision/segmental resection 468 (10.2%)
Lobectomy/hepatectomy 490 (10.7%)
Chemotherapy
No/unknown 2127 (46.3%)
Yes 2468 (53.7%)
Radiotherapy
No/unknown 3899 (84.9%)
Yes 696 (15.1%)

API/AI American Indian/AK Native, Asian/Pacific Islander.